Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 3 clinical trials
Featured trial
SPROUT - Pediatric Psoriasis - CC-10004 PPSO 003 - Canada

This is a Phase 3, multicenter, randomized, placebo-controlled, double-blind study of the efficacy and safety of apremilast (CC-10004) in pediatric subjects with moderate to severe plaque

  • 0 views
  • 05 Sep, 2022
Featured trial
Have been diagnosed with moderate to severe Ulcerative Colitis?

Have been diagnosed with moderate to severe Ulcerative Colitis?

  • 72 views
  • 08 Nov, 2020
  • 1 location
A Phase 3b, Multi Center, Open-label, Long-term Extension Study of Apremilast (CC-10004) in Pediatric Subjects From 6 Through 17 Years of Age With Moderate to Severe Plaque Psoriasis

This study was created to provide subjects who complete Week 52 (end of Apremilast Extension Phase) of study CC-10004-PPSO-003 the option to continue to receive open-label apremilast therapy

apremilast
cervical cap
option 2
cc-10004
tubal ligation
  • 0 views
  • 14 Oct, 2022
  • 48 locations